Jacobs Levy Equity Management
SQZ

Jacobs Levy Equity Management’s SQZ Biotechnologies Company SQZ Stock Holding History

Jacobs Levy Equity Management’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-67,609
Closed -$325K – 1125
2022
Q1 		$325K Buy
+67,609
New +$429K ﹤0.01% 909
2021
Q3 		– Sell
-69,189
Closed -$1M – 1153
2021
Q2 		$1M Buy
69,189
+45,159
+188% +$590K 0.01% 741
2021
Q1 		$329K Buy
+24,030
New +$488K ﹤0.01% 921

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management's SQZ Position: Q2 2022 in Review

Jacobs Levy Equity Management sold out of SQZ Biotechnologies Company (SQZ) in Q2 2022, closing a stake of 67,609 shares — an estimated $325K sold.

Jacobs Levy Equity Management first reported a position in SQZ in Q1 2021 and held it in 3 quarters. The position peaked at $1M in Q2 2021. 53 funds tracked by Wall St. Rank hold SQZ as of Q2 2022.

  • Jacobs Levy Equity Management reported no remaining SQZ Biotechnologies Company position as of Q2 2022 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 67,609 SQZ Biotechnologies Company shares in Q2 2022, an estimated $325K.
  • Jacobs Levy Equity Management first reported a position in SQZ Biotechnologies Company in Q1 2021 and held it in 3 quarters.
  • Jacobs Levy Equity Management's SQZ Biotechnologies Company position peaked at $1M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2022, filed 15 Aug 2022.